Evidence map›Paper›PMID 30899575›Full record

ArticleBMJ global health2019

Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings.

Laura T Mazzola, Cassandra Kelly-Cirino

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Establishment of a Lassa Fever Specimen Biobank in Nigeria.The American journal of tropical medicine and hygiene · 2025
    Article
  6. Article
  7. Article
  8. Lassa Fever: Critical Review and Prospects for Control.Tropical medicine and infectious disease · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Lassa Virus Genetics.Current topics in microbiology and immunology · 2023
    Article
  14. Review
  15. The niche of One Health approaches in Lassa fever surveillance and control.Annals of clinical microbiology and antimicrobials · 2021
    Review
  16. Article
  17. Review
  18. Lassa Fever: An Evolving Emergency in West Africa.The American journal of tropical medicine and hygiene · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Laura T MazzolaFIND, Emerging Threats Programme, Geneva, Switzerland.
Cassandra Kelly-CirinoFIND, Emerging Threats Programme, Geneva, Switzerland.
Foundation for Innovative New Diagnostics · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lassa fever virus (LASV) causes acute viral haemorrhagic fever with symptoms similar to those seen with Ebola virus infections. LASV is endemic to West Africa and is transmitted through contact with excretions of infected

Indexed as

in-vitro diagnosticsLassa fever virusLASVoutbreak

Identifiers

PMID30899575
PMCPMC6407561
OpenAlexW2914293572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.